Kennedy D W, Abkowitz J L
Division of Hematology, University of Washington, Seattle 98195, USA.
Blood. 1997 Aug 1;90(3):986-93.
To determine the kinetics of tissue macrophage and microglial engraftment after bone marrow (BM) transplantation, we have developed a model using the ROSA 26 mouse. Transplanted ROSA 26 cells can be precisely identified in recipient animals because they constitutively express beta-galactosidase (beta-gal) and neomycin resistance. B6/129 F2 mice were irradiated and transplanted with BM from ROSA 26 donors and their tissues (spleen, marrow, brain, liver, and lung) examined at various time points to determine the kinetics of engraftment. Frozen sections from transplanted animals were stained histochemically for beta-gal to identify donor cells. At 1, 2, 6, and 12 months posttransplantation, 98% to 100% of granulocyte-macrophage colonies were of donor (ROSA 26) origin determined by beta-gal staining and by neomycin resistance. Splenic monocytes/macrophages were 89% donor origin by 1 month confirming quick and complete engraftment of hematopoietic tissues. At this time, only rare ROSA 26 tissue macrophages or microglia were observed. Alveolar macrophage engraftment was evident by 2 months and had increased to 61% of total tissue macrophages at 1 year posttransplantation. The kinetics of liver Kupffer cell engraftment were similar to those seen in the lung. However, donor microglial engraftment remained only 23% of total microglia at 6 months and increased to only 30% by 1 year. Also, donor microglia were predominantly seen at perivascular and leptomeningeal, and not parenchymal, sites. The data show that microglia derive from BM precursors but turn over at a significantly slower rate than other tissue macrophages. No clinical or histological graft-versus-host disease was observed in the recipients of ROSA 26 BM. These kinetics may impact strategies for the gene therapy of lysosomal storage diseases. Because individual donor cells can be identified in situ, the ROSA 26 model should have many applications in transplantation biology including studies of homing and differentiation.
为了确定骨髓(BM)移植后组织巨噬细胞和小胶质细胞的植入动力学,我们利用ROSA 26小鼠建立了一个模型。移植的ROSA 26细胞在受体动物中能够被精确识别,因为它们组成性表达β-半乳糖苷酶(β-gal)和新霉素抗性。对B6/129 F2小鼠进行照射,并移植来自ROSA 26供体的骨髓,在不同时间点检查其组织(脾脏、骨髓、脑、肝脏和肺)以确定植入动力学。对移植动物的冰冻切片进行β-gal组织化学染色以识别供体细胞。移植后1、2、6和12个月,通过β-gal染色和新霉素抗性确定,98%至100%的粒细胞-巨噬细胞集落来源于供体(ROSA 26)。到1个月时,脾脏单核细胞/巨噬细胞89%来源于供体,证实造血组织快速且完全植入。此时,仅观察到罕见的ROSA 26组织巨噬细胞或小胶质细胞。肺泡巨噬细胞植入在2个月时明显可见,移植后1年增加到占总组织巨噬细胞的61%。肝脏枯否细胞的植入动力学与肺中的相似。然而,供体小胶质细胞在6个月时仅占小胶质细胞总数的23%,到1年时仅增加到30%。此外,供体小胶质细胞主要见于血管周围和软脑膜部位,而非实质部位。数据表明,小胶质细胞来源于BM前体细胞,但更新速度明显慢于其他组织巨噬细胞。在接受ROSA 26 BM移植的受体中未观察到临床或组织学的移植物抗宿主病。这些动力学可能会影响溶酶体贮积病基因治疗的策略。由于可以在原位识别单个供体细胞,ROSA 26模型在移植生物学中应有许多应用,包括归巢和分化研究。